Diagnostic Biosystems Usa Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 47.69%
- Profit Growth -4.19%
- Ebitda -3.39%
- Net Worth -48.96%
- Total Assets 36.04%
About Diagnostic Biosystems Usa
Diagnostic Biosystems Usa Private Limited (DBUPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 31 July 2019 (Five years and six months 10 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bipin Gupta and Ananda Meesala serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U52609TG2019FTC134481
-
Company No.
134481
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
31 Jul 2019
-
Date of AGM
07 Oct 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Diagnostic Biosystems Usa?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bipin Gupta
|
Director | 31-Jul-2019 | Current |
Ananda Meesala
|
Director | 31-Jul-2019 | Current |
Financial Performance of Diagnostic Biosystems Usa.
Diagnostic Biosystems Usa Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.69% increase. The company also saw a slight decrease in profitability, with a 4.19% decrease in profit. The company's net worth observed a substantial decline by a decrease of 48.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagnostic Biosystems Usa?
In 2023, Diagnostic Biosystems Usa had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diagnostic Biosystems Usa?
Unlock and access historical data on people associated with Diagnostic Biosystems Usa, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagnostic Biosystems Usa, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagnostic Biosystems Usa's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.